FT Live US Pharma and Biotech Summit 2023 - Day 2

R&D
FT Live US Pharma and Biotech Summit 2023 - Day 2

For the second and final day of the FT US Pharma and Biotech Summit, day 2 kicks off with a session on cell and gene therapies. As the day goes on, speakers will cover changes in R&D, patient-driven trends in commercialisation, drug development, and clinical trial transformation.

We’ll hear from Amgen CEO Robert Bradway, Pfizer chief development officer William Pao, and Roche CEO Teresa Graham before the event wraps at 4 pm. Read on below for the live blog which will update throughout the day.